Between mistrust and restrictions, what future for the AstraZeneca vaccine?

Between Mistrust and Restrictions, What Future for the AstraZeneca Vaccine?

People under 55 who have already received a dose of AstraZeneca will be offered a different vaccine for the second dose. In some departments where the South African virus circulates extensively, the High Authority of Health (HAS) recommends not to use it. Indispensable to the vaccination objectives, will the vaccine remain stranded? The storm never ends for […]

Continue Reading
Possible links between the Johnson & Johnson coronavirus vaccine and Thrombosis

Possible Links Between the Johnson & Johnson Vaccine and Cases of Thrombosis

The European Medicines Agency announced this Friday 9th April, to launch a study on the possible links between four cases of thrombosis, including one fatal, and the Johnson & Johnson coronavirus vaccine After AstraZeneca, Johnson & Johnson? This Friday 9th April, the European Medicines Agency (EMA) launched a study on the American single-dose vaccine. The safety commission […]

Continue Reading
Three new cases of thrombosis and two deaths reported in France due to the AstraZeneca vaccine.

AstraZeneca: Three New Cases of Thrombosis and Two Deaths Reported in France

PANDEMIC: The ANSM, which recalls the benefit of the AstraZeneca vaccine, provides a list of symptoms to watch out for after vaccination Three new cases of atypical thrombosis associated with AstraZeneca’s Covid-19 vaccine, with two additional deaths, occurred in France between March 19th and 25th, according to the Medicines Agency (ANSM). Since the start of the vaccination, there are “twelve cases, […]

Continue Reading
Vaccination: The drug agency confirms a rare risk of thrombosis associated with the AstraZeneca vaccine

Vaccination: The Drug Agency Confirms a Risk of Rare Thrombosis Associated with the AstraZeneca Vaccine

PANDEMIC: The ANSM stresses however that the benefit/risk balance of the AstraZeneca Covid-19 vaccine remained “favourable” The Medical Products Agency (ANSM) Friday confirmed the existence of a risk “rare” atypical thrombosis associated with the vaccine against Covid-19 from AstraZeneca, after the occurrence of new cases in France, including two deaths, while by emphasizing that the risk/benefit balance remained “favourable”. […]

Continue Reading
In Nantes, a student dies of thrombosis after AstraZeneca vaccine

Coronavirus: Nantes Student Dies of Thrombosis After AstraZeneca Vaccine

DEATH: The Nantes medical student was found dead on March 18th in his Nantes apartment after being vaccinated with AstraZeneca earlier this month. However, there is nothing to make the link between the death and the vaccine. The Nantes medical student was found dead on March 18 in his Nantes apartment after being vaccinated with AstraZeneca […]

Continue Reading